COMPASS Pathways plc (CMPS)
NASDAQ: CMPS · Real-Time Price · USD
3.260
-0.120 (-3.55%)
At close: Jul 3, 2025, 1:00 PM
3.231
-0.029 (-0.89%)
After-hours: Jul 3, 2025, 4:59 PM EDT
COMPASS Pathways Market Cap
COMPASS Pathways has a market cap or net worth of $305.01 million as of July 3, 2025. Its market cap has decreased by -34.40% in one year.
Market Cap
305.01M
Enterprise Value
76.93M
1-Year Change
-34.40%
Ranking
Category
Stock Price
$3.26
Market Cap Chart
Since the IPO on September 18, 2020, COMPASS Pathways's market cap has decreased from $568.58M to $305.01M, a decrease of -46.36%. That is a compound annual growth rate of -12.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 305.01M | 17.93% |
| Dec 31, 2024 | 258.63M | -52.25% |
| Dec 29, 2023 | 541.59M | 58.41% |
| Dec 30, 2022 | 341.89M | -62.93% |
| Dec 31, 2021 | 922.26M | -46.12% |
| Dec 31, 2020 | 1.71B | 201.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |